查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
生殖遗传学市场-全球行业规模、份额、趋势、机会、预测，2018-2028 年，按成分、技术、程序类型、应用、地区、竞争
市场调查报告书
商品编码
1255249

生殖遗传学市场-全球行业规模、份额、趋势、机会、预测，2018-2028 年，按成分、技术、程序类型、应用、地区、竞争

Reproductive Genetics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F Segmented by Component, By Technology, By Procedure Type, By Application, By Region and Competition
出版日期: | 出版商: TechSci Research | 英文 113 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

预计全球生殖遗传学市场在预测期内将出现显着增长。

在此背景下，发展中国家对基因工程的认识提高，获得更好的医疗服务成为可能。 此外，随着医疗检测报销的改善以及政府机构为开发新的诊断中心进行的多项投资，世界不同地区对生殖遗传学的需求显着增加。 此外，高级检测的显着增加以及各年龄段女性对安全生活的意识不断增强，也将进一步增加对生殖遗传学的需求，并推动市场增长到 2027 年。预计 此外，人们对计划生育的兴趣增加、有利的政府法规以及各种测试的进步预计将进□□一步增加对生殖遗传学的需求并支持市场的增长。 同样，基因技术的进步和该技术在临床医学中的采用将促进其在遗传病检测、携带者筛查和不孕症鑑定方面的应用，预计在预测期内进一步推动市场增长。

对基因检测的需求不断增长

对怀孕期间产生的胚胎进行基因检测和针对可能的遗传疾病进行体外受精的需求不断增长，这正在推动生殖遗传学市场的增长。 通过体外受精技术对胚胎进行基因检测的市场发展和基因检测的一些发展使人工生殖中的遗传疾病检测成为可能，从而推动了预测期内的市场增长。 生殖遗传学可以帮助识别胚胎中的缺陷，这样父母就可以采用体外受精等替代程序来增加健康的怀孕和婴儿，而不管患者的健康状况如何，预计这将在预测期内持续下去。这将进一步推动市场。 根据 Statista 的数据，截至 2019 年，纽约是美国合法堕胎数量最多的州，同年报告的堕胎超过 78,000 起。 佛罗里达州也报告了超过 71,000 起堕胎，其次是德克萨斯州，超过 57,000 起。 2019年美国共有63万例合法堕胎。

推进基因组技术

基因组技术的进步及其在临床医学中的应用，以及在遗传病诊断、携带者筛查、不孕原因鑑定等方面的应用，正在推动预测期内的市场增长。 然而，有些测试非常昂贵，以至于不鼓励夫妇进行这些测试。 然而，人口测序成本的下降和混血儿人口的激增预计将增加选择新程序的夫妇和个人，这有望在预测期内推动市场增长。 出生缺陷影响美国每年出生的 33 个婴儿中的 1 个（约占所有活产婴儿的 3%）。

近期发展

  • 2021 年 5 月 Juno Diagnostics 是一家专注于改善遗传健康信息获取途径的公司，宣布了由 Perceptive Xontogeny Venture (PXV) Fund 领投的 2500 万美元 A 轮融资。宣布它是完全的。 这笔资金将支持产品开发、临床验证研究以及 JunoDx 无创产前检测的商业发布。
  • 2020 年 3 月 Agilent宣布推出三款用于产前和产后研究的新型微阵列芯片。 该微阵列包含来自权威数据库的最新临床相关内容。 新一代测序技术的进步发现了新的基因-疾病关联，并且数据库正在迅速发展以包含这些发现。

自定义

根据市场数据，TechSci Research 根据公司的具体需求提供定制服务。 该报告可以定制为：

公司信息

  • 对其他市场参与者（最多 5 家）进行深入分析和概况分析。

内容

第 1 章概述

  • 市场定义
  • 市场范围
    • 目标市场
    • 研究目标年份
    • 主要市场细分

第二章研究方法论

  • 调查目的
  • 基线调查方法
  • 主要行业合作伙伴
  • 主要协会和次要信息
  • 调查方法
  • 数据三角测量和验证
  • 假设和限制

第 3 章执行摘要

  • 市场概览
  • 主要市场细分概述
  • 主要市场参与者概览
  • 主要地区/国家概览
  • 市场驱动因素、挑战和趋势

第 4 章 VOC（客户之声）

第五章全球生殖遗传学市场展望

  • 市场规模和预测
    • 按金额
  • 市场份额和预测
    • 按组件（实验室诊断、试剂盒和化验、试剂和消耗品）
    • 按技术（新一代测序、聚合□炼式反应、原位杂交、微阵列）
    • 按程序类型（携带者筛查、产前筛查、植入前基因检测、不育基因检测）
    • 按应用（非整倍体、单基因畸变、结构染色体畸变、其他）
    • 按地区
    • 按公司分类（2022 年）
  • 市场地图
    • 按组件
    • 按技术
    • 按程序类型
    • 通过申请
    • 按地区

第6章北美生殖遗传学市场展望

  • 市场规模和预测
    • 按金额
  • 市场份额和预测
    • 按组件
    • 按技术
    • 按程序类型
    • 通过申请
    • 按国家
  • 北美：国家/地区分析
    • 美国
    • 加拿大
    • 墨西哥

第七章欧洲生殖遗传学市场前景

  • 市场规模和预测
    • 按金额
  • 市场份额和预测
    • 按组件
    • 按技术
    • 按程序类型
    • 通过申请
    • 按国家
  • 欧洲：国家分析
    • 法国
    • 德国
    • 英国
    • 意大利
    • 西班牙

第八章亚太地区生殖遗传学市场展望

  • 市场规模和预测
    • 按金额
  • 市场份额和预测
    • 按组件
    • 按技术
    • 按程序类型
    • 通过申请
    • 按国家
  • 亚太地区：国家/地区分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳大利亚

第9章南美生殖遗传学市场展望

  • 市场规模和预测
    • 按金额
  • 市场份额和预测
    • 按组件
    • 按技术
    • 按程序类型
    • 通过申请
    • 按国家
  • 南美洲：国家分析
    • 巴西
    • 阿根廷
    • 哥伦比亚

第 10 章中东和非洲生殖遗传学市场前景

  • 市场规模和预测
    • 按金额
  • 市场份额和预测
    • 按组件
    • 按技术
    • 按程序类型
    • 通过申请
    • 按国家
  • MEA：国家分析
    • 南非
    • 沙特阿拉伯
    • 阿联酋
    • 土耳其人
    • 埃及

第 11 章市场动态

  • 司机
  • 任务

第12章市场趋势与发展

  • 近期趋势
  • 併购
  • 产品发布

第13章竞争格局

  • 业务概览
  • 产品供应
  • 最近的发展
  • 财务（据报导）
  • 主要人员
  • SWOT 分析
    • CooperSurgical, Inc.
    • Centogene AG
    • Invitae Corporation
    • Illumina, Inc.
    • Myriad Genetics, Inc.,
    • Thermo Fisher Scientific Inc.
    • Laboratory Corporation of America Holdings
    • Quest Diagnostics
    • Natera, Inc
    • Eurofins Scientific SE

第 14 章战略建议

简介目录
Product Code: 14339

The global reproductive genetics market is anticipated to witness impressive growth during the forecast period. This can be ascribed to the growing awareness of genetic engineering in developing countries to get better. Additionally, growing reimbursement improvements for medical tests and initiatives, running parallel to multiple investments by government organizations for developing new diagnostic centers, have significantly increased the demand for reproductive genetics across different parts of the globe. Additionally, significant growth in advanced testing, along with increasing awareness among different age groups of women for a leading safe life, is further expected to increase the demand for reproductive genetics, thereby fuelling the market growth through 2027. Furthermore, increasing focus on family planning, favorable regulations by the government, and advancements in different testing are further expected to increase the demand for reproductive genetics, thereby supporting market growth. Similarly, advancement in geno9mic technologies and implementation of this technology in clinical medicine will enhance the usage in genetic disorder testing, carrier screening, and identification of infertility which will further boost the growth of the market during the forecast period.

Increasing demand for Genetic Testing

Increasing demand for genetic testing of embryos, either during pregnancy or of those created through IVF to check for possible genetic disorders, is driving the growth of the reproductive genetics market. Increasing genetic testing for embryos through IVF technology and several developments in genetic testing are making it possible to test for genetic disorders in artificial reproduction, which is driving the market growth during the forecast period. Reproductive genetics help to identify embryo defects so that parents can adopt alternative procedures like IVF, thus increasing the healthy pregnancy and baby regardless of patient health, which will further boost the market during the forecast period. According to Statista, as of 2019, the leading state by the number of legal abortions in the United States was New York, which reported over 78 thousand abortions that year. Florida also reported over 71 thousand abortions, followed by Texas with over 57 thousand. There was a total of 630000 legal abortions in the United States in 2019.

Growing Advancement in Genomic Technologies

Increasing advancement in genomic technologies and further implementation of these technologies in clinical medicine have enhanced their usage in the diagnosis of genetic disorders, carrier screening, and identification of the cause of infertility, propelling the market growth in the forecast period. Some tests are much more expensive, which helps couples from going ahead with the tests. However, with the decline in the cost of sequencing and the surge in the mixed-ethnicity population, an increasing number of couples/individuals are expected to opt for the new procedure, which is expected to drive the market growth during the forecast period. Birth defects affect one in every 33 babies (about 3% of all babies) born in the United States each year.

Market Segmentation

The global reproductive genetics market can be segmented by component, technology, procedure type, application, and by region. Based on components, the market can be segmented into Laboratory Developed Tests, Kits & Assays, and Reagents & Consumables. Based on technology, the market can be segmented into Next Generation Sequencing, Polymerase Chain Reaction, In Situ Hybridization, and Microarrays. Based on procedure type, the market can be differentiated into Carrier Screening, Prenatal Screening, Preimplantation Genetic Testing, and Infertility Genetic Testing. Based on application, the market can be grouped into Aneuploidy, Single Gene Disorder, Structural Chromosomal Abnormality, and Others. Regionally, North America dominated the market among Asia Pacific, Europe, Middle East & Africa, and South America. Among the different countries, the United States dominated the global reproductive genetics market on account of the increasing demand for genetic testing to identify genetic abnormalities in the country.

Recent Developments

  • In May 2021, Juno Diagnostics, Which is a company focusing on enhancing access to genetic health information, announced the closing of a Series A financing round for USD 25 million led by Perceptive Xontogeny Venture (PXV) Fund. The fund will support product development, clinical validation studies, and the commercial launch of JunoDx's product offerings for non-invasive prenatal testing.
  • In March 2020, Agilent Technologies announced the launch of three new microarrays for prenatal and postnatal research. The microarray includes updated clinically relevant content from respected databases. Progression of next-generation sequencing is uncovering new gene-disease associations, and databases are rapidly evolving to include these discoveries.

Market Players

CooperSurgical, Inc., Centogene AG, Invitae Corporation, Illumina, Inc., Myriad Genetics, Inc., Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, Quest Diagnostics, Natera, Inc, Eurofins Scientific SE are some of the leading players operating in the Global Reproductive Genetics Market.

Report Scope

In this report, global reproductive genetics market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Reproductive Genetics Market, By Component:

  • Laboratory-Developed Tests
  • Kits & Assays
  • Reagents & Consumables

Reproductive Genetics Market, By Technology:

  • Next-Generation Sequencing
  • Polymerase Chain Reaction
  • In Situ Hybridization, Microarrays

Reproductive Genetics Market, By Procedure Type:

  • Carrier Screening
  • Prenatal Screening
  • Preimplantation Genetic Testing
  • Infertility Genetic Testing

Reproductive Genetics Market, By Application:

  • Aneuploidy
  • Single Gene Disorder
  • Structural Chromosomal Abnormality
  • Others

Reproductive Genetics Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • United Kingdom
    • Italy
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Turkey
    • Egypt

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global Reproductive Genetics Market.

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Reproductive Genetics Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Component (Laboratory Developed Tests, Kits & Assays, Reagents & Consumables)
    • 5.2.2. By Technology (Next Generation Sequencing, Polymerase Chain Reaction, In Situ Hybridization, Microarrays)
    • 5.2.3. By Procedure Type (Carrier Screening, Prenatal Screening, Preimplantation Genetic Testing, Infertility Genetic Testing)
    • 5.2.4. By Application (Aneuploidy, Single Gene Disorder, Structural Chromosomal Abnormality, Others)
    • 5.2.5. By Region
    • 5.2.6. By Company (2022)
  • 5.3. Market Map
    • 5.3.1. By Component
    • 5.3.2. By Technology
    • 5.3.3. By Procedure Type
    • 5.3.4. By Application
    • 5.3.5. By Region

6. North America Reproductive Genetics Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Component
    • 6.2.2. By Technology
    • 6.2.3. By Procedure Type
    • 6.2.4. By Application
    • 6.2.5. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Reproductive Genetics Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Component
        • 6.3.1.2.2. By Technology
        • 6.3.1.2.3. By Procedure Type
        • 6.3.1.2.4. By Application
    • 6.3.2. Canada Reproductive Genetics Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Component
        • 6.3.2.2.2. By Technology
        • 6.3.2.2.3. By Procedure Type
        • 6.3.2.2.4. By Application
    • 6.3.3. Mexico Reproductive Genetics Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Component
        • 6.3.3.2.2. By Technology
        • 6.3.3.2.3. By Procedure Type
        • 6.3.3.2.4. By Application

7. Europe Reproductive Genetics Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Component
    • 7.2.2. By Technology
    • 7.2.3. By Procedure Type
    • 7.2.4. By Application
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Reproductive Genetics Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Component
        • 7.3.1.2.2. By Technology
        • 7.3.1.2.3. By Procedure Type
        • 7.3.1.2.4. By Application
    • 7.3.2. Germany Reproductive Genetics Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Component
        • 7.3.2.2.2. By Technology
        • 7.3.2.2.3. By Procedure Type
        • 7.3.2.2.4. By Application
    • 7.3.3. United Kingdom Reproductive Genetics Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Component
        • 7.3.3.2.2. By Technology
        • 7.3.3.2.3. By Procedure Type
        • 7.3.3.2.4. By Application
    • 7.3.4. Italy Reproductive Genetics Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Component
        • 7.3.4.2.2. By Technology
        • 7.3.4.2.3. By Procedure Type
        • 7.3.4.2.4. By Application
    • 7.3.5. Spain Reproductive Genetics Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Component
        • 7.3.5.2.2. By Technology
        • 7.3.5.2.3. By Procedure Type
        • 7.3.5.2.4. By Application

8. Asia-Pacific Reproductive Genetics Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Component
    • 8.2.2. By Technology
    • 8.2.3. By Procedure Type
    • 8.2.4. By Application
    • 8.2.5. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Reproductive Genetics Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Component
        • 8.3.1.2.2. By Technology
        • 8.3.1.2.3. By Procedure Type
        • 8.3.1.2.4. By Application
    • 8.3.2. India Reproductive Genetics Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Component
        • 8.3.2.2.2. By Technology
        • 8.3.2.2.3. By Procedure Type
        • 8.3.2.2.4. By Application
    • 8.3.3. Japan Reproductive Genetics Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Component
        • 8.3.3.2.2. By Technology
        • 8.3.3.2.3. By Procedure Type
        • 8.3.3.2.4. By Application
    • 8.3.4. South Korea Reproductive Genetics Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Component
        • 8.3.4.2.2. By Technology
        • 8.3.4.2.3. By Procedure Type
        • 8.3.4.2.4. By Application
    • 8.3.5. Australia Reproductive Genetics Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Component
        • 8.3.5.2.2. By Technology
        • 8.3.5.2.3. By Procedure Type
        • 8.3.5.2.4. By Application

9. South America Reproductive Genetics Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Component
    • 9.2.2. By Technology
    • 9.2.3. By Procedure Type
    • 9.2.4. By Application
    • 9.2.5. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Reproductive Genetics Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Component
        • 9.3.1.2.2. By Technology
        • 9.3.1.2.3. By Procedure Type
        • 9.3.1.2.4. By Application
    • 9.3.2. Argentina Reproductive Genetics Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Component
        • 9.3.2.2.2. By Technology
        • 9.3.2.2.3. By Procedure Type
        • 9.3.2.2.4. By Application
    • 9.3.3. Colombia Reproductive Genetics Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Component
        • 9.3.3.2.2. By Technology
        • 9.3.3.2.3. By Procedure Type
        • 9.3.3.2.4. By Application

10. Middle East and Africa Reproductive Genetics Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Component
    • 10.2.2. By Technology
    • 10.2.3. By Procedure Type
    • 10.2.4. By Application
    • 10.2.5. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Reproductive Genetics Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Component
        • 10.3.1.2.2. By Technology
        • 10.3.1.2.3. By Procedure Type
        • 10.3.1.2.4. By Application
    • 10.3.2. Saudi Arabia Reproductive Genetics Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Component
        • 10.3.2.2.2. By Technology
        • 10.3.2.2.3. By Procedure Type
        • 10.3.2.2.4. By Application
    • 10.3.3. UAE Reproductive Genetics Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Component
        • 10.3.3.2.2. By Technology
        • 10.3.3.2.3. By Procedure Type
        • 10.3.3.2.4. By Application
    • 10.3.4. Turkey Reproductive Genetics Market Outlook
      • 10.3.4.1. Market Size & Forecast
        • 10.3.4.1.1. By Value
      • 10.3.4.2. Market Share & Forecast
        • 10.3.4.2.1. By Component
        • 10.3.4.2.2. By Technology
        • 10.3.4.2.3. By Procedure Type
        • 10.3.4.2.4. By Application
    • 10.3.5. Egypt Reproductive Genetics Market Outlook
      • 10.3.5.1. Market Size & Forecast
        • 10.3.5.1.1. By Value
      • 10.3.5.2. Market Share & Forecast
        • 10.3.5.2.1. By Component
        • 10.3.5.2.2. By Technology
        • 10.3.5.2.3. By Procedure Type
        • 10.3.5.2.4. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Developments
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Competitive Landscape

  • 13.1. Business Overview
  • 13.2. Product Offerings
  • 13.3. Recent Developments
  • 13.4. Financials (As Reported)
  • 13.5. Key Personnel
  • 13.6. SWOT Analysis
    • 13.6.1. CooperSurgical, Inc.
    • 13.6.2. Centogene AG
    • 13.6.3. Invitae Corporation
    • 13.6.4. Illumina, Inc.
    • 13.6.5. Myriad Genetics, Inc.,
    • 13.6.6. Thermo Fisher Scientific Inc.
    • 13.6.7. Laboratory Corporation of America Holdings
    • 13.6.8. Quest Diagnostics
    • 13.6.9. Natera, Inc
    • 13.6.10. Eurofins Scientific SE

14. Strategic Recommendations